Prognostic Biomarkers Identification in Esophageal Cancer Based on WGCNA and Single-Cell Analysis

Figure 5

Difference analysis and prognostic analysis of hub genes (ANGPT2, VCAN, MS4A4A, and FOS). (a–d) Prognostic analysis of hub genes (ANGPT2, VCAN, MS4A4A, and FOS) in patients with esophageal cancer. (e) Intersection between genes in important modules of WGCNA and differential genes in normal and tumor tissues. (f) Difference analysis of hub genes (ANGPT2, VCAN, MS4A4A, and FOS) between normal tissues and tumor tissues.

(a)

(b)

(c)

(d)

(e)

(f)